Literature DB >> 11872675

Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.

Cecilia Mur1, Angela M Valverde, C Ronald Kahn, Manuel Benito.   

Abstract

Immortalized brown adipocyte cell lines have been generated from fetuses of mice deficient in the insulin-like growth factor I receptor gene (IGF-IR(-/-)), as well as from fetuses of wild-type mice (IGF-IR(+/+)). These cell lines maintained the expression of adipogenic- and thermogenic-differentiation markers and show a multilocular fat droplets phenotype. IGF-IR(-/-) brown adipocytes lacked IGF-IR protein expression; insulin receptor (IR) expression remained unchanged as compared with wild-type cells. Insulin-induced tyrosine autophosphorylation of the IR beta-chain was augmented in IGF-IR--deficient cells. Upon insulin stimulation, tyrosine phosphorylation of (insulin receptor substrate-1) IRS-1 was much higher in IGF-IR(-/-) brown adipocytes, although IRS-1 protein content was reduced. In contrast, tyrosine phosphorylation of IRS-2 decreased in IGF-IR--deficient cells; its protein content was unchanged as compared with wild-type cells. Downstream, the association IRS-1/growth factor receptor binding protein-2 (Grb-2) was augmented in the IGF-IR(-/-) brown adipocyte cell line. However, SHC expression and SHC tyrosine phosphorylation and its association with Grb-2 were unaltered in response to insulin in IGF-IR--deficient brown adipocytes. These cells also showed an enhanced activation of mitogen-activated protein kinase (MAPK) kinase (MEK1/2) and p42/p44 mitogen-activated protein kinase (MAPK) upon insulin stimulation. In addition, the lack of IGF-IR in brown adipocytes resulted in a higher mitogenic response (DNA synthesis, cell number, and proliferating cell nuclear antigen expression) to insulin than wild-type cells. Finally, cells lacking IGF-IR showed a much lower association between IR or IRS-1 and phosphotyrosine phosphatase 1B (PTP1B) and also a decreased PTP1B activity upon insulin stimulation. However, PTP1B/Grb-2 association remained unchanged in both cell types, regardless of insulin stimulation. Data presented here provide strong evidence that IGF-IR--deficient brown adipocytes show an increased insulin sensitivity via IRS-1/Grb-2/MAPK, resulting in an increased mitogenesis in response to insulin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872675     DOI: 10.2337/diabetes.51.3.743

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Essential Role of IGFIR in the Onset of Male Brown Fat Thermogenic Function: Regulation of Glucose Homeostasis by Differential Organ-Specific Insulin Sensitivity.

Authors:  Vanesa Viana-Huete; Carlos Guillén; Ana García-Aguilar; Gema García; Silvia Fernández; C R Kahn; Manuel Benito
Journal:  Endocrinology       Date:  2016-02-24       Impact factor: 4.736

2.  Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription.

Authors:  Jeremie Boucher; Yu-Hua Tseng; C Ronald Kahn
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

3.  Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.

Authors:  C Owen; E K Lees; L Grant; D J Zimmer; N Mody; K K Bence; M Delibegović
Journal:  Diabetologia       Date:  2013-07-06       Impact factor: 10.122

4.  Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes.

Authors:  R Hernandez; T Teruel; M Lorenzo
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

5.  Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes.

Authors:  Angela M Valverde; Cecilia Mur; Michael Brownlee; Manuel Benito
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

6.  Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells.

Authors:  Niels Engberding; Alejandra San Martín; Abel Martin-Garrido; Mitsuhisa Koga; Lily Pounkova; Erin Lyons; Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-02       Impact factor: 8.311

7.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

8.  Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth.

Authors:  Nora Klöting; Linda Koch; Thomas Wunderlich; Matthias Kern; Karen Ruschke; Wilhelm Krone; Jens C Brüning; Matthias Blüher
Journal:  Diabetes       Date:  2008-04-28       Impact factor: 9.461

9.  Endothelial insulin and IGF-1 receptors: when yes means NO.

Authors:  Ranganath Muniyappa; James R Sowers
Journal:  Diabetes       Date:  2012-09       Impact factor: 9.461

Review 10.  Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment.

Authors:  Kunal Amratlal Lodhia; Piyawan Tienchaiananda; Paul Haluska
Journal:  Front Oncol       Date:  2015-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.